These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13164012)

  • 1. Synergistic effects of antituberculous agents on streptomycin resistant tubercle bacilli. I. In vitro synergistic effects of antituberculous agents on the growth of tubercle bacilli with different degrees of resistance to streptomycin.
    OKADA T
    Kekkaku; 1954 Feb; 29(2):47-54. PubMed ID: 13164012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synergistic effects of antituberculous agents on streptomycin resistant tubercle bacilli. 2. Synergistic effects in vivo of SM and other drugs on the SM (10r/cc) resistant tubercle bacilli].
    OKADA T
    Kekkaku; 1955 Feb; 30(2):72-80; English summary, 100. PubMed ID: 14382205
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of low-frequency ultrasound on Mycobacterium tuberculosis].
    Shaĭkhaev AIa; Makarevich NM
    Probl Tuberk; 1989; (10):43-6. PubMed ID: 2512572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. IV. Antituberculous activities of R.P in vitro under various inadequate conditions for the growth of tubercle bacilli].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):43-9. PubMed ID: 6442175
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental studies on the synergic effect of antituberculous agents. III. Influence of the combined application of antituberculous agents on the resistance of in vivo tubercle bacilli.
    MIZUNO M
    Kekkaku; 1953 Jul; 28(7):356-7. PubMed ID: 13085554
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in morphology & mode of development of tubercle bacilli & other Mycobacteria caused by antituberculous agents. V. Morphological studies on drug-resistant strains of Mycobacteria and the transformation of susceptible cells to resistant ones under the low levels of the drugs].
    ITO Y
    Kekkaku; 1958 Sep; 33(9):602-7; English abstract 646. PubMed ID: 13599181
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effects of antituberculous drugs on the catalase-activities of sensitive and resistant strains of human type tubercle bacilli].
    NAKANO Y
    Kekkaku; 1956 Dec; 31(12):733-6. PubMed ID: 13406904
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro.
    COHN ML; MIDDLEBROOK G; RUSSELL WF
    J Clin Invest; 1959 Aug; 38(8):1349-55. PubMed ID: 13673091
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative study of the relationship between the growth rate of tubercle bacilli and the concentration of antituberculous agents (author's transl)].
    Tsukamura M; Mizuno S
    Kekkaku; 1980 Aug; 55(8):365-70. PubMed ID: 6775122
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of antituberculous drugs on the morphology of tubercle bacilli studied by the slide culture method].
    HIROTANI F
    Kekkaku; 1958 May; 33(5):363-9; English abstract, 375. PubMed ID: 13550403
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the virulence of streptomycin-resistant tubercle bacilli.
    MURATA T
    Kekkaku; 1953 Sep; 28(9):464. PubMed ID: 13131491
    [No Abstract]   [Full Text] [Related]  

  • 12. [The sensitivity determination of tubercle bacilli to antituberculous drugs. I. A simple method for pouring the antituberculous drugs into solid media].
    HIRASAWA I
    Kekkaku; 1955 Apr; 30(4):199-202; English summary, 213. PubMed ID: 14392690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in morphology and mode of development of tubercle bacilli and other mycobacteria caused by antituberculous agents. II. The changes in the initial minute colonies of mycobacteria caused by isonicotinic acid hydrazide].
    ITO Y
    Kekkaku; 1958 Jun; 33(6):408-11; English abstract 445. PubMed ID: 13564623
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of the virulence of tubercle bacilli by selection of streptomycin-resistant mutant].
    HASHIMOTO T; SEKINE O
    Kekkaku; 1954 Oct; 29(10):383-7; English summary, 416-7. PubMed ID: 13212970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical and genetic studies on the appearance of streptomycin resistant organisms in tubercle bacilli].
    SUGIYAMA M; TANAKA S
    Kekkaku; 1954 Nov; 29(11):445-55; English summary, 463-4. PubMed ID: 13234144
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance of tubercle bacilli to streptomycin, PAS & isoniazid].
    KRAAN JK
    Ned Tijdschr Geneeskd; 1958 Nov; 102(47):2314-8. PubMed ID: 13622796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].
    Sayğan MB; Ocak F; Cesur S; Tarhan G; Ceyhan I; Gümüişlü F; Beker G; Güner U; Coşkun E
    Mikrobiyol Bul; 2007 Jul; 41(3):403-9. PubMed ID: 17933251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug resistance of tubercle bacilli in experimental animals treated with streptomycin and isoniazid].
    USHIBA D; ABE I; ENDO T; KUSAMA H
    Kekkaku; 1955 Mar; 30(3):114-8; English summary, 154-5. PubMed ID: 14382212
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in morphology and mode of development of tubercle bacilli and other mycobacteria caused by anti-tuberculous agents. IV. The survival and the recovery of growth of cells after treatment with streptomycin or isoniazid].
    ITO Y
    Kekkaku; 1958 Aug; 33(8):533-5; English abstract, 578. PubMed ID: 13588760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.